Congenital Hematological Disorder Completed Phase 4 Trials for Coagulation factor VII human (DB13150)

Back to Congenital Hematological Disorder

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01561391Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major SurgeryTreatment
NCT00571584High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With InhibitorsTreatment
NCT00108797Trial of NovoSeven® in Haemophilia - Joint BleedsTreatment